Stealth BioTherapeutics Awarded Grant from The Michael J. Fox Foundation to Support Development of SBT-272 in Parkinson's Disease
/PRNewswire/ -- Stealth BioTherapeutics, (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development, and...
Source: prnewswire.com